Intuitive Surgical (NASDAQ:ISRG) Downgraded by Wall Street Zen to Hold

Intuitive Surgical (NASDAQ:ISRG) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Other analysts have also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. UBS Group set a $529.00 target price on shares of Intuitive Surgical in a research report on Monday. The Goldman Sachs Group dropped their target price on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research report on Wednesday, October 1st. Mizuho dropped their target price on shares of Intuitive Surgical from $570.00 to $520.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Fourteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $580.29.

Intuitive Surgical Trading Up 2.6%

Shares of Intuitive Surgical stock opened at $446.13 on Friday. The firm has a fifty day simple moving average of $454.97 and a 200-day simple moving average of $495.83. Intuitive Surgical has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market capitalization of $159.93 billion, a price-to-earnings ratio of 62.22, a PEG ratio of 4.56 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. During the same period in the previous year, the company earned $1.78 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.4% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 in the last 90 days. 0.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently bought and sold shares of ISRG. Chilton Capital Management LLC increased its holdings in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the period. Tobam grew its holdings in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. Elite Financial Inc. bought a new stake in shares of Intuitive Surgical in the 1st quarter worth about $26,000. Kilter Group LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth about $27,000. Finally, LFA Lugano Financial Advisors SA bought a new stake in shares of Intuitive Surgical in the 1st quarter worth about $30,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.